๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer

โœ Scribed by Daniel J. Booser; Francisco J. Esteva; Edgardo Rivera; Vicente Valero; Laura Esparza-Guerra; Waldemar Priebe; Gabriel N. Hortobagyi


Publisher
Springer
Year
2002
Tongue
English
Weight
56 KB
Volume
50
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Caelyx (stealth liposomal doxorubicin) i
โœ M.R. Ranson; S. Cheeseman; S. White; J. Margison ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 77 KB

Anthracyclines are amongst the most active drugs in the treatment of breast cancer. Stealth liposomal doxorubicin (Caelyx, Doxil, Alza Pharmaceuticals Inc.) is a promising new agent under investigation for the treatment of breast cancer and other solid tumours. The liposomal encapsulation alters dru